LAG3 and neoplasm: Both LAG3 and TIM3 are frequently co-expressed with PD-1 on anergic or exhausted tumor-specific CD8+ T cell, and for this reason, escape from PD-1 pathway blockade could be achieved by additive expression of co-inhibitory receptors on CD8+ T cells.